However, the inhibition of mTOR with an mTOR inhibitor (everolimus) reduced the tumor growth in xenograft mice, but did not shrink the tumor size, probably due to the increased activity of Akt and ERK by this drug, confirming the c-MET-dependent resistance of the tumor [142]. The gene discussed is AKT1; the disease is neoplasm.